Hamamatsu Photonics KK
TSE:6965
Hamamatsu Photonics KK
TSE:6965
Price:
1 765.5
JPY
0.68%
Market Closed
Market Cap:
582.9B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Hamamatsu Photonics KK
1765.5
+12.0 (+0.68%)
| 52 Week Range |
1 638
3 005.404
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Hamamatsu Photonics KK
Balance Sheet
Balance Sheet Decomposition
Hamamatsu Photonics KK
Hamamatsu Photonics KK
| Current Assets | 239B |
| Cash & Short-Term Investments | 99.9B |
| Receivables | 45.3B |
| Other Current Assets | 93.8B |
| Non-Current Assets | 195.6B |
| Long-Term Investments | 4.4B |
| PP&E | 132.9B |
| Intangibles | 35.7B |
| Other Non-Current Assets | 22.6B |
| Current Liabilities | 80.7B |
| Accounts Payable | 13.4B |
| Accrued Liabilities | 6.9B |
| Short-Term Debt | 25.3B |
| Other Current Liabilities | 35.2B |
| Non-Current Liabilities | 22.6B |
| Long-Term Debt | 8.5B |
| Other Non-Current Liabilities | 14.1B |
Balance Sheet
Hamamatsu Photonics KK
Hamamatsu Photonics KK
Currency: JPY
| Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
81 548
|
74 503
|
83 902
|
74 458
|
78 414
|
73 763
|
91 087
|
125 999
|
119 128
|
97 021
|
|
| Cash Equivalents |
81 548
|
74 503
|
83 902
|
74 458
|
78 414
|
73 763
|
91 087
|
125 999
|
119 128
|
97 021
|
|
| Short-Term Investments |
0
|
1 000
|
0
|
0
|
3 646
|
6 634
|
8 671
|
2 316
|
2 393
|
2 854
|
|
| Total Receivables |
28 581
|
27 728
|
33 449
|
35 752
|
35 207
|
32 065
|
42 335
|
49 524
|
50 226
|
45 315
|
|
| Accounts Receivables |
28 581
|
27 728
|
33 449
|
35 752
|
35 207
|
32 065
|
42 335
|
49 524
|
50 226
|
45 315
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
29 475
|
30 043
|
31 751
|
34 484
|
37 528
|
43 512
|
44 401
|
59 076
|
75 554
|
80 569
|
|
| Other Current Assets |
7 556
|
7 234
|
7 732
|
5 503
|
5 114
|
7 319
|
5 626
|
9 123
|
13 549
|
13 250
|
|
| Total Current Assets |
147 160
|
140 508
|
156 834
|
150 197
|
159 909
|
163 293
|
192 120
|
246 038
|
260 850
|
239 009
|
|
| PP&E Net |
66 854
|
64 292
|
68 291
|
71 730
|
77 450
|
86 341
|
86 479
|
95 200
|
113 648
|
132 895
|
|
| PP&E Gross |
66 854
|
64 292
|
68 291
|
71 730
|
77 450
|
86 341
|
86 479
|
95 200
|
113 648
|
132 895
|
|
| Accumulated Depreciation |
127 327
|
133 566
|
138 787
|
145 771
|
153 808
|
163 132
|
172 776
|
182 471
|
190 997
|
209 401
|
|
| Intangible Assets |
1 766
|
1 463
|
1 697
|
6 278
|
5 324
|
5 035
|
4 853
|
5 359
|
5 136
|
4 904
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30 827
|
|
| Long-Term Investments |
3 067
|
2 921
|
4 524
|
5 266
|
4 678
|
4 396
|
5 252
|
5 431
|
5 878
|
4 386
|
|
| Other Long-Term Assets |
7 332
|
8 116
|
7 985
|
11 443
|
12 333
|
12 550
|
12 972
|
14 149
|
17 409
|
22 613
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30 827
|
|
| Total Assets |
226 179
N/A
|
217 300
-4%
|
239 331
+10%
|
244 914
+2%
|
259 694
+6%
|
271 615
+5%
|
301 676
+11%
|
366 177
+21%
|
402 921
+10%
|
434 634
+8%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
13 512
|
13 460
|
14 098
|
11 367
|
12 656
|
11 832
|
14 758
|
17 382
|
17 169
|
13 353
|
|
| Accrued Liabilities |
3 480
|
3 613
|
4 570
|
5 138
|
4 768
|
4 500
|
5 814
|
7 926
|
7 265
|
6 933
|
|
| Short-Term Debt |
2 040
|
2 183
|
2 230
|
1 662
|
1 454
|
1 511
|
3 507
|
4 799
|
5 854
|
25 281
|
|
| Current Portion of Long-Term Debt |
3 172
|
218
|
3 194
|
3 276
|
260
|
441
|
3 410
|
2 546
|
1 575
|
3 114
|
|
| Other Current Liabilities |
13 629
|
12 402
|
15 967
|
16 635
|
20 291
|
23 118
|
24 804
|
36 869
|
36 637
|
32 053
|
|
| Total Current Liabilities |
35 833
|
31 876
|
40 059
|
38 078
|
39 429
|
41 402
|
52 293
|
69 522
|
68 500
|
80 734
|
|
| Long-Term Debt |
3 808
|
6 844
|
3 683
|
3 715
|
6 504
|
6 960
|
3 767
|
5 113
|
7 400
|
8 522
|
|
| Deferred Income Tax |
176
|
182
|
272
|
619
|
646
|
576
|
583
|
544
|
336
|
231
|
|
| Minority Interest |
629
|
553
|
618
|
668
|
689
|
834
|
1 048
|
1 340
|
1 413
|
1 704
|
|
| Other Liabilities |
5 592
|
8 682
|
7 759
|
8 517
|
9 468
|
9 162
|
7 463
|
9 094
|
6 626
|
12 136
|
|
| Total Liabilities |
46 038
N/A
|
48 137
+5%
|
52 391
+9%
|
51 597
-2%
|
56 736
+10%
|
58 934
+4%
|
65 154
+11%
|
85 613
+31%
|
84 275
-2%
|
103 327
+23%
|
|
| Equity | |||||||||||
| Common Stock |
34 928
|
34 928
|
34 928
|
34 928
|
34 928
|
34 964
|
35 008
|
35 048
|
35 095
|
35 146
|
|
| Retained Earnings |
110 637
|
119 259
|
131 678
|
142 321
|
156 036
|
166 357
|
185 206
|
217 195
|
247 922
|
261 277
|
|
| Additional Paid In Capital |
34 672
|
34 672
|
34 672
|
34 672
|
34 672
|
34 708
|
34 752
|
34 792
|
34 374
|
34 426
|
|
| Unrealized Security Profit/Loss |
520
|
455
|
1 259
|
1 545
|
744
|
742
|
1 191
|
921
|
1 109
|
1 096
|
|
| Treasury Stock |
6 059
|
16 059
|
16 060
|
20 795
|
20 795
|
20 795
|
20 797
|
20 798
|
20 798
|
20 798
|
|
| Other Equity |
5 443
|
4 092
|
463
|
646
|
2 627
|
3 295
|
1 162
|
13 406
|
20 944
|
20 160
|
|
| Total Equity |
180 141
N/A
|
169 163
-6%
|
186 940
+11%
|
193 317
+3%
|
202 958
+5%
|
212 681
+5%
|
236 522
+11%
|
280 564
+19%
|
318 646
+14%
|
331 307
+4%
|
|
| Total Liabilities & Equity |
226 179
N/A
|
217 300
-4%
|
239 331
+10%
|
244 914
+2%
|
259 694
+6%
|
271 615
+5%
|
301 676
+11%
|
366 177
+21%
|
402 921
+10%
|
434 634
+8%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
161
|
157
|
157
|
155
|
155
|
155
|
310
|
310
|
310
|
310
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
